StockData

Dianthus Therapeutics, Inc. (DNTH) stock

DNTHNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 7/30
$91.81−0.67 (-0.72%)

Close on Nov 13, 2026Market cap $5.14BP/E –Yield 0.00%

Dianthus Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Dianthus Therapeutics's market cap was $4.89B on Nov 11, 2026, against $1.88B a year earlier. Over the last 5 years it ranged from $5.78M to $5.84B, with a median of $564.43M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$4.89B+177.1%
2025Dec 31, 2025$1.77B+175.9%
2024Dec 31, 2024$640.19M+315.4%
2023Dec 29, 2023$154.10M+2564.1%
2022Dec 30, 2022$5.78M-90.7%
2021Dec 31, 2021$62.18M-31.2%
2020Dec 31, 2020$90.42M-35.9%
2019Dec 31, 2019$140.98M+212.9%
2018Dec 31, 2018$45.06M–

More Dianthus Therapeutics figures

See a number that looks wrong?